In Russia, thanks to the newest vaccine, cancer was defeated for the first time.
The first patient who received the oncobic vaccine has already completed the treatment: his metastases disappeared and everything is fine with him for four months," said Alexander Ginzburg, academician of the Russian Academy of Sciences, scientific director of the N.F. Gamalia Center.
Now he is checked once a month, and such an observation is intended for three years. A detailed computed tomography scan with a resolution of up to tenths of a millimeter is performed on the patient by the head of the National Center for Medical Research in Radiology, Andrey Kaprin: the doctors examine him from head to toe, first of all checking the lymph nodes.
The academy explained the mechanism of action of the mRNA vaccine using its device: the patient's immune system is adapted so that it itself destroys the malignant tumor and metastases. An individual medicine is prepared for each patient based on his genetic data, because no two tumors are the same.
For the first time in clinical practice, the personalized antitumor mRNA vaccine Neooncovac was administered to a patient with cutaneous melanoma in April.